The increasing adoption of IT within the healthcare sector may be a crucial factor to drive the expansion of the market. The higher adoption rates within the emerging economies, growing need for developing the standard of care, increasing need for decreasing human errors, and escalating chronic disease population are the opposite important factors that are expected to boost the expansion of the clinical decision network market. Rapid improvements within the fields of biotechnology and bioinformatics are boosting enhancements and optimizations in data storage, administration, and analytics platforms.
The marketplace is predicted to watch an outsized number of modifications following R&D projects strengthened up by large corporate investments. The combination of cloud computing and interoperability programs in several systems will further improve smooth functioning and seamless data flow, thereby raising the adoption of CDSS.
Increasing specialises in quality care and accuracy medicine is additionally projected to fuel revenue production. Clinical and drug-related data stored on the cloud are often accessed only by accredited users. Integration with Electronic Health Record (EHR) increases the effectiveness of clinical care by decreasing the time to look for patient’s clinical records. Over the past few years, the evolution of collaborations among CDSS providers and hospitals has observed a big increase.
Companies are involved in partnerships to market and supply software updated with the newest data. Government is promoting and taking various initiatives to boost the adoption of CDSS and EHR systems are considered to further increase the demand of Clinical Decision Support Systems Market. However, the shortage of skilled labour and lack of belief within the systems as CDSS is within the initial stage of development are the factors which will limit the expansion of the worldwide clinical decision support system market.
Covid-19 Impact on Clinical Decision Support Systems/CDSS Market:
In addition, the current Global Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Global Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Clinical Decision Support Systems/CDSS Market Segment Overview
By Delivery Mode, the market is bifurcated into standalone delivery systems and cloud-based delivery systems. The standalone Delivery System is accounted for the most important share of the CDSS market and is predicted to still dominate the market throughout the forecast horizon. It’s widely adopted due to its moderate cost and ease. Ease to use in hospitals and clinical contexts has contributed to its highest share.
By Application, the market is bifurcated into clinical drug information, disease and condition management, clinical informatics and surveillance, et al. Clinical informatics and surveillance are expected to dominate the market over the forecast period, due to the increasing adoption of CDSS for this purpose.
By End-User, the market is bifurcated into Clinics, Hospitals, Ambulatory Surgical Centers, and Others. The hospitals held the most important market share in 2019 and are forecasted to witness a rate of growth over the forecast period. The factors, including well-resourced diagnostic rooms, tremendous purchasing power, the presence of highly skilled healthcare professionals, and enhanced health coverage for hospital-based healthcare services will drive market demand.
Market Analysis, Insights and Forecast – By Delivery Mode
• Standalone Delivery System
• Cloud-based Delivery System
Market Analysis, Insights and Forecast – By End Use
• Clinics
• Hospitals
• Ambulatory Surgical Centers
• Others
Market Analysis, Insights and Forecast – By Application
• Clinical Drug Information
• Disease and Condition Management
• Clinical Informatics and Surveillance
• Others
Clinical Decision Support Systems/CDSS Market Regional Overview
Region-wise, in terms of regions, North America is predicted to dominate the market over the forecast period. The rising demand for healthcare information technology solutions within the medical sector is anticipated to propel the regional market. Rapid technological advancements and a growing emphasis on quality healthcare services are contributing to the expansion of this region. The market within the APAC is predicted to grow at the best CAGR over succeeding five years. Factors like the presence of oversized geriatric population, improved government legislation, the high burden of chronic diseases, and therefore the growing focus of varied market players on emerging Asian countries are expected to drive the expansion of the CDSS market in Asia.
Clinical Decision Support Systems/CDSS Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Clinical Decision Support Systems/CDSS Market Competitor overview
Some key developments and strategies adopted by manufacturers in the Clinical Decision Support Systems/CDSS are highlighted below.
· In 2017, Mayo Clinic partnered with Epic to allow Mayo’s clinical decision database to merge with Epic’s EHR.
Clinical Decision Support Systems/CDSS Market, Key Players
· Wolters Kluwer Health
· Hearst Health
· International Business Machines (IBM)
· Elsevier B.V.
· Philips Healthcare
· Cerner Corporation
· McKesson Corporation
· Allscripts Healthcare Solutions, Inc.
· MEDITECH
· Epic Systems Corporation.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Clinical Decision Support Systems/CDSS Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Delivery Mode
- 5.2.1. Standalone Delivery System
- 5.2.2. Cloud-based Delivery System
- 5.3. Market Analysis, Insights and Forecast – By End Use
- 5.3.1. Clinics
- 5.3.2. Hospitals
- 5.3.3. Ambulatory Surgical Centers
- 5.3.4. Others
- 5.4. Market Analysis, Insights and Forecast – By Application
- 5.4.1. Clinical Drug Information
- 5.4.2. Disease and Condition Management
- 5.4.3. Clinical Informatics and Surveillance
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast – By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East, and Africa
6. North America Clinical Decision Support Systems/CDSS Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Delivery Mode
- 6.2.1. Standalone Delivery System
- 6.2.2. Cloud-based Delivery System
- 6.3. Market Analysis, Insights and Forecast – By End Use
- 6.3.1. Clinics
- 6.3.2. Hospitals
- 6.3.3. Ambulatory Surgical Centers
- 6.3.4. Others
- 6.4. Market Analysis, Insights and Forecast – By Application
- 6.4.1. Clinical Drug Information
- 6.4.2. Disease and Condition Management
- 6.4.3. Clinical Informatics and Surveillance
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast – By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Clinical Decision Support Systems/CDSS Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Delivery Mode
- 7.2.1. Standalone Delivery System
- 7.2.2. Cloud-based Delivery System
- 7.3. Market Analysis, Insights and Forecast – By End Use
- 7.3.1. Clinics
- 7.3.2. Hospitals
- 7.3.3. Ambulatory Surgical Centers
- 7.3.4. Others
- 7.4. Market Analysis, Insights and Forecast – By Application
- 7.4.1. Clinical Drug Information
- 7.4.2. Disease and Condition Management
- 7.4.3. Clinical Informatics and Surveillance
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast – By Country
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Clinical Decision Support Systems/CDSS Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Delivery Mode
- 8.2.1. Standalone Delivery System
- 8.2.2. Cloud-based Delivery System
- 8.3. Market Analysis, Insights and Forecast – By End Use
- 8.3.1. Clinics
- 8.3.2. Hospitals
- 8.3.3. Ambulatory Surgical Centers
- 8.3.4. Others
- 8.4. Market Analysis, Insights and Forecast – By Application
- 8.4.1. Clinical Drug Information
- 8.4.2. Disease and Condition Management
- 8.4.3. Clinical Informatics and Surveillance
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast – By Country
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East, and Africa Clinical Decision Support Systems/CDSS Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Delivery Mode
- 9.2.1. Standalone Delivery System
- 9.2.2. Cloud-based Delivery System
- 9.3. Market Analysis, Insights and Forecast – By End Use
- 9.3.1. Clinics
- 9.3.2. Hospitals
- 9.3.3. Ambulatory Surgical Centers
- 9.3.4. Others
- 9.4. Market Analysis, Insights and Forecast – By Application
- 9.4.1. Clinical Drug Information
- 9.4.2. Disease and Condition Management
- 9.4.3. Clinical Informatics and Surveillance
- 9.4.4. Others
- 9.5. Market Analysis, Insights and Forecast – By Country
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Wolters Kluwer Health
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. Hearst Health
- 10.6. International Business Machines (IBM)
- 10.7. Elsevier B.V.
- 10.8. Philips Healthcare
- 10.9. Cerner Corporation
- 10.10. McKesson Corporation
- 10.11. Allscripts Healthcare Solutions, Inc.
- 10.12. MEDITECH
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
